MedTrace Logo

A Study Assessing Patient Handling of Flutiform® Breath-Actuated Inhaler (BAI) and Flutiform® Pressurised Metered Dose Inhaler (pMDI)

NCT01739387 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 332

Last updated 2013-06-28

No results posted yet for this study

Summary

This study will compare the patient handling of Flutiform® pMDI (pressurised metered dose inhaler) and a breath activated device (BAI). Patient handling will be assessed using assessment criteria which detail the correct handling steps for each inhaler.

Conditions

Interventions

DEVICE

Flutiform® pMDI and Breath Actuated Inhaler (BAI)

Both devices contain placebo

Sponsors & Collaborators

  • Mundipharma Research Limited

    lead INDUSTRY

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01739387 on ClinicalTrials.gov